Jon Edwards, PhD | Non-executive Director
Jon Edwards is a Principal in the investment team at Medicxi, with a main focus on early-stage opportunities. Prior to Medicxi, Jon worked at Index as an Associate for two years. Before that, he worked as a life science strategy consultant at ClearView Healthcare Partners.
Next to being a boardmember at Xenikos, Jon is also on the boards of Palladio Biosciences, Z-Factor, UltraHuman Ltd and Impact Biomedicines (sold to Celgene). He is also an observer on the board of Capella Bioscience, Apcintex and Sydnexis.
Jon obtained his PhD in biochemistry and biophysics from UNC Chapel Hill and also conducted postdoctoral research at MI